Literature DB >> 2459204

Competition between unrelated peptides recognized by H-2-Kd restricted T cells.

P Pala1, H C Bodmer, R M Pemberton, J C Cerottini, J L Maryanski, B A Askonas.   

Abstract

P815 (H-2d) target cells incubated with synthetic peptides corresponding to region 170-182 of HLA or to region 141-161 of influenza nucleoprotein (NP) are lysed by DBA/2 derived cytolytic T cells (CTL) specific for HLA or by BALB/c derived CTL-specific for NP, respectively. Both peptide Ag are recognized in the context of Kd. We show herein that these unrelated, nonhomologous peptides clearly compete reciprocally for recognition by the appropriate Kd restricted CTL. In contrast, different NP peptides that are recognized by other CTL restricted by HLA-B37, H-2-Db or KK, either failed to compete or were much less efficient as competitors than NP peptides recognized in the context of Kd. The efficiency of a peptide as a competitor correlated with its potency as an Ag. The most efficient competitor was a variant peptide of NP 147-158 with R156 deleted, which had been previously shown to be 1,000 times more efficient as an Ag than its natural homolog. Our results suggest that peptides recognized by CTL in the context of the same MHC class I restriction element may bind to the same or interdependent site(s) on the restriction molecule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459204

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: implications for control of viral disease.

Authors:  J E Gairin; M B Oldstone
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 2.  Peptide presentation by class-I major histocompatibility complex molecules.

Authors:  J Nikolić-Zugić; F R Carbone
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Influenza peptide-induced self-lysis and down-regulation of cloned cytotoxic T cells.

Authors:  R M Pemberton; D C Wraith; B A Askonas
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

4.  Influenza-specific cytotoxic T-cell recognition is inhibited by peptides unrelated in both sequence and MHC restriction.

Authors:  H C Bodmer; J M Bastin; B A Askonas; A R Townsend
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

5.  Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames.

Authors:  Damien J Zanker; Sara Oveissi; David C Tscharke; Mubing Duan; Siyuan Wan; Xiaomu Zhang; Kun Xiao; Nicole A Mifsud; James Gibbs; Lenny Izzard; Daniel Dlugolenski; Pierre Faou; Karen L Laurie; Nathalie Vigneron; Ian G Barr; John Stambas; Benoît J Van den Eynde; Jack R Bennink; Jonathan W Yewdell; Weisan Chen
Journal:  J Immunol       Date:  2019-05-15       Impact factor: 5.422

6.  Immunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoprotein.

Authors:  Li Chen; Damien Zanker; Kun Xiao; Chao Wu; Quanming Zou; Weisan Chen
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

7.  Identification of residues necessary for clonally specific recognition of a cytotoxic T cell determinant.

Authors:  J B Rothbard; R M Pemberton; H C Bodmer; B A Askonas; W R Taylor
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

8.  Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes.

Authors:  N L Lill; M J Tevethia; W G Hendrickson; S S Tevethia
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.